Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Development of Asthma in Inner-City Children: Possible Roles of MAIT Cells and Variation in the Home Environment.

Chandra S, Wingender G, Greenbaum JA, Khurana A, Gholami AM, Ganesan AP, Rosenbach M, Jaffee K, Gern JE, Wood R, O'Connor G, Sandel M, Kattan M, Bacharier L, Togias A, Horner AA, Kronenberg M.

J Immunol. 2018 Mar 15;200(6):1995-2003. doi: 10.4049/jimmunol.1701525. Epub 2018 Feb 5.

PMID:
29431692
2.

Correction: Cryptic chytridiomycosis linked to climate and genetic variation in amphibian populations of the southeastern United States.

Horner AA, Hoffman EA, Tye MR, Hether TD, Savage AE.

PLoS One. 2017 Oct 3;12(10):e0186066. doi: 10.1371/journal.pone.0186066. eCollection 2017.

3.

Cryptic chytridiomycosis linked to climate and genetic variation in amphibian populations of the southeastern United States.

Horner AA, Hoffman EA, Tye MR, Hether TD, Savage AE.

PLoS One. 2017 Apr 27;12(4):e0175843. doi: 10.1371/journal.pone.0175843. eCollection 2017. Erratum in: PLoS One. 2017 Oct 3;12 (10 ):e0186066.

4.

House dust bioactivities predict skin prick test reactivity for children with high risk of allergy.

Kim H, Tse K, Levin L, Bernstein D, Reponen T, LeMasters G, Lummus Z, Horner AA.

J Allergy Clin Immunol. 2012 Jun;129(6):1529-37.e2. doi: 10.1016/j.jaci.2012.01.051. Epub 2012 Mar 3.

5.

Invariant NKT cells are required for airway inflammation induced by environmental antigens.

Wingender G, Rogers P, Batzer G, Lee MS, Bai D, Pei B, Khurana A, Kronenberg M, Horner AA.

J Exp Med. 2011 Jun 6;208(6):1151-62. doi: 10.1084/jem.20102229. Epub 2011 May 30.

6.

Regulatory T cells contribute to allergen tolerance induced by daily airway immunostimulant exposures.

Lee SM, Batzer G, Ng N, Lam D, Pattar SS, Patel ND, Horner AA.

Am J Respir Cell Mol Biol. 2011 Mar;44(3):341-9. doi: 10.1165/rcmb.2010-0001OC. Epub 2010 May 6.

7.

Regulation of aeroallergen immunity by the innate immune system: laboratory evidence for a new paradigm.

Horner AA.

J Innate Immun. 2010;2(2):107-13. doi: 10.1159/000227761. Epub 2009 Jul 2. Review.

8.

Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity.

Brydges SD, Mueller JL, McGeough MD, Pena CA, Misaghi A, Gandhi C, Putnam CD, Boyle DL, Firestein GS, Horner AA, Soroosh P, Watford WT, O'Shea JJ, Kastner DL, Hoffman HM.

Immunity. 2009 Jun 19;30(6):875-87. doi: 10.1016/j.immuni.2009.05.005. Epub 2009 Jun 4.

9.

Allergen-independent immunomodulatory activities of immunoglobulin E.

Horner AA, Kawakami T.

Clin Exp Allergy. 2009 Mar;39(3):304-6. doi: 10.1111/j.1365-2222.2008.03182.x. Epub 2009 Jan 22. No abstract available.

10.

Allergen tolerance versus the allergic march: the hygiene hypothesis revisited.

Tse K, Horner AA.

Curr Allergy Asthma Rep. 2008 Nov;8(6):475-83. Review.

11.
12.

Update on toll-like receptor-directed therapies for human disease.

Tse K, Horner AA.

Ann Rheum Dis. 2007 Nov;66 Suppl 3:iii77-80. Review.

13.

Defining a role for ambient TLR ligand exposures in the genesis and prevention of allergic diseases.

Tse K, Horner AA.

Semin Immunopathol. 2008 Feb;30(1):53-62. Epub 2007 Nov 8. Review.

PMID:
17989979
14.

Using house dust extracts to understand the immunostimulatory activities of living environments.

Batzer G, Lam DP, Paulus P, Boasen J, Ng N, Horner AA.

Immunobiology. 2007;212(6):491-8. Epub 2007 Apr 30.

15.

Update on toll-like receptor ligands and allergy: implications for immunotherapy.

Horner AA.

Curr Allergy Asthma Rep. 2006 Sep;6(5):395-401. Review.

PMID:
16899201
16.

Toll-like receptor ligands and atopy: a coin with at least two sides.

Horner AA.

J Allergy Clin Immunol. 2006 May;117(5):1133-40. Review.

PMID:
16675343
17.

House dust extracts have both TH2 adjuvant and tolerogenic activities.

Ng N, Lam D, Paulus P, Batzer G, Horner AA.

J Allergy Clin Immunol. 2006 May;117(5):1074-81.

PMID:
16675335
18.

House dust extracts elicit Toll-like receptor-dependent dendritic cell responses.

Boasen J, Chisholm D, Lebet L, Akira S, Horner AA.

J Allergy Clin Immunol. 2005 Jul;116(1):185-91.

PMID:
15990793
19.

Toll-like receptor ligands: hygiene, atopy and therapeutic implications.

Horner AA, Redecke V, Raz E.

Curr Opin Allergy Clin Immunol. 2004 Dec;4(6):555-61. Review.

PMID:
15640699
20.

Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis.

Rhee CS, Libet L, Chisholm D, Takabayashi K, Baird S, Bigby TD, Lee CH, Horner AA, Raz E.

Immunology. 2004 Sep;113(1):106-13.

21.

Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications.

Datta SK, Cho HJ, Takabayashi K, Horner AA, Raz E.

Immunol Rev. 2004 Jun;199:217-26. Review.

PMID:
15233737
22.

Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities.

Chisholm D, Libet L, Hayashi T, Horner AA.

J Allergy Clin Immunol. 2004 Mar;113(3):448-54.

PMID:
15007346
23.

Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapy.

Spiegelberg HL, Horner AA, Takabayashi K, Raz E.

Curr Opin Allergy Clin Immunol. 2002 Dec;2(6):547-51. Review.

PMID:
14752340
24.
25.
27.

Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity.

Horner AA, Takabayashi K, Beck L, Sharma B, Zubeldia J, Baird S, Tuck S, Libet L, Spiegelberg HL, Liu FT, Raz E.

J Allergy Clin Immunol. 2002 Sep;110(3):413-20.

PMID:
12209088
28.

Immunostimulatory DNA-based therapeutics for experimental and clinical allergy.

Horner AA, Takabaysahi K, Zubeldia JM, Raz E.

Allergy. 2002;57 Suppl 72:24-9. Review.

29.

Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells.

Horner AA, Widhopf GF, Burger JA, Takabayashi K, Cinman N, Ronaghy A, Spiegelberg HL, Raz E.

J Allergy Clin Immunol. 2001 Sep;108(3):417-23.

PMID:
11544462
30.

Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites.

Horner AA, Datta SK, Takabayashi K, Belyakov IM, Hayashi T, Cinman N, Nguyen MD, Van Uden JH, Berzofsky JA, Richman DD, Raz E.

J Immunol. 2001 Aug 1;167(3):1584-91.

31.

DNA-based vaccination for the treatment of food allergy.

Nguyen MD, Cinman N, Yen J, Horner AA.

Allergy. 2001;56 Suppl 67:127-30. Review.

32.

DNA-based immunotherapeutics for the treatment of allergic disease.

Horner AA, Van Uden JH, Zubeldia JM, Broide D, Raz E.

Immunol Rev. 2001 Feb;179:102-18. Review.

PMID:
11292014
33.

Mucosal adjuvanticity of immunostimulatory DNA sequences.

Horner AA, Cinman N, Ronaghy A, Raz E.

Springer Semin Immunopathol. 2000;22(1-2):133-46. Review. No abstract available.

PMID:
10944808
34.

Pre-priming: a novel approach to DNA-based vaccination and immunomodulation.

Kobayashi H, Horner AA, Martin-Orozco E, Raz E.

Springer Semin Immunopathol. 2000;22(1-2):85-96. Review. No abstract available.

PMID:
10944803
35.

DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice.

Horner AA, Nguyen MD, Ronaghy A, Cinman N, Verbeek S, Raz E.

J Allergy Clin Immunol. 2000 Aug;106(2):349-56.

PMID:
10932080
36.

Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant.

Horner AA, Raz E.

Clin Immunol. 2000 Apr;95(1 Pt 2):S19-29.

PMID:
10729234
37.

Immunostimulatory-sequence DNA is an effective mucosal adjuvant.

Horner AA, Raz E.

Curr Top Microbiol Immunol. 2000;247:185-98. Review. No abstract available.

PMID:
10689788
38.

Immunostimulatory DNA pre-priming: a novel approach for prolonged Th1-biased immunity.

Kobayashi H, Horner AA, Takabayashi K, Nguyen MD, Huang E, Cinman N, Raz E.

Cell Immunol. 1999 Nov 25;198(1):69-75.

PMID:
10612653
39.

Immunostimulatory DNA is a potent mucosal adjuvant.

Horner AA, Ronaghy A, Cheng PM, Nguyen MD, Cho HJ, Broide D, Raz E.

Cell Immunol. 1998 Nov 25;190(1):77-82.

PMID:
9826449
41.

gamma/delta T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes.

Horner AA, Jabara H, Ramesh N, Geha RS.

J Exp Med. 1995 Mar 1;181(3):1239-44.

43.

Penile vasculitis with impending necrosis treated with prostaglandin E1 infusion.

Horner AA, Dunn K, Stiehm ER.

Am J Dis Child. 1991 Jun;145(6):604. No abstract available.

PMID:
2035486
46.
47.
48.

Location of antithrombin-binding regions in rat skin heparin proteoglycans.

Jacobsson KG, Lindahl U, Horner AA.

Biochem J. 1986 Dec 15;240(3):625-32.

50.

Supplemental Content

Loading ...
Support Center